Tag: Medical devices
-
Exploring access and reimbursement of digital medical devices and AI-based SaMD at ISPOR Europe 2024
How to approach reimbursement and access of DMDs? DMD reimbursement remains a highly dynamic, where complex access options need to be carefully evaluated, followed and potentially re-evaluated. While access strategy needs to be tailored to each device, some general questions for the DMD field should be considered for each evidence generation plan and go-to-market plan:…
-
The dynamics in diagnostic imaging tenders and funding
Reimbursement, access, competition and purchasing are highly dynamic in the diagnostic imaging technology field.
-
Apersy’s 1st anniversary
I started with the vision to create independent market access services that can support health tech companies through the challenges of precision medicine, complex treatment regimens and care approaches that blur the boundaries between device, pharmaceuticals and digital.
-
Announcement of UK IDAP Pilot for medical devices – What does it mean for reimbursement?
The Innovative Devices Access Pathway (IDAP) Pilot is a first step to providing a faster and supported route to regulatory approval, access and adoption of innovative devices. But what precisely does this mean ultimately for access and reimbursement?
-
French PECAN reimbursement applications have started… It’s not a DiGA copy-paste
…. the fundamental differences in the French and German access paths for digital medical devices
-
France PLFSS 2023: Social security financing bill puts pressure on medicine pricing
France PLFSS 2023: Social security financing bill puts pressure on medicine pricing The draft of the French social security financing law for the year to come (PLFSS 2023) includes a few proposals that could have an impact on innovative medicine pricing, including ATMPs and products eligible for the “European price”, meaning products that have demonstrated…